EODData

MEMBERSHIP REGISTER LOG IN

OTCBB, EVLO: Evelo Biosciences Inc

26 Nov 2025
LAST:

0.0005

CHANGE:
 0.00		OPEN:
0.0005		HIGH:
0.0005		ASK:
0.0000		VOLUME:
1.4K
CHG(%):
0.00		PREV:
0.0005		LOW:
0.0005		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
26 Nov 250.00050.00050.00050.00051.4K
20 Nov 250.00050.00050.00050.0005200
10 Nov 250.00050.00050.00050.0005109.6K

PROFILE

Name:Evelo Biosciences Inc
About:Evelo Biosciences, Inc., a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis. The company is also developing EDP1867, a non-live pharmaceutical preparation for single strain of Veillonella parvula, which is in Phase 1b clinical trial; EDP2939, an investigational oral biologic for the potential treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Sector:Healthcare
Industry:Biotechnology
Address:620 Memorial Drive, Cambridge, MA, United States, 02139
Website:https://www.evelobio.com
CUSIP:299734103
CIK:0001694665
ISIN:US2997341035
FIGI:BBG00H43XR69

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:0.000.0%
MA10:0.000.0%
MA20:0.0025.0%
MA50:0.000.0%
MA100:0.000.0%
STO9:100.00 
STO14:100.00 
RSI14:50.00
ATR:0.00 
Week High:0.000.0%
Week Low:0.000.0%
Month High:0.000.0%
Month Low:0.00

RECENT SPLITS

Date Ratio
30 Jun 20231-20